)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
NATCO Pharma (NATCOPHARM) investor relations material
NATCO Pharma Q1 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 25/26 earnings summary13 Aug, 2025
Executive summary
Q1 FY26 total revenue was ₹13,906 million, down from ₹14,107 million year-over-year, with pharma export formulations contributing ₹11,265 million and domestic formulations ₹1,070 million.
EBITDA for the quarter was ₹6,327 million with a margin of 45.5%.
Net profit stood at ₹4,803 million, down 28% year-over-year, and EPS was ₹26.84.
Interim dividend of ₹2 per equity share declared for Q1 FY26.
Net cash as of June 30, 2025, was ₹34,740 million.
Financial highlights
Revenue declined year-over-year due to US pricing pressure and higher R&D and other expenses.
EBITDA margin dropped to 45.5% from 60.5% in Q1FY25.
PAT margin was 34.5% in Q1FY26, down from 47.4% in Q1FY25.
Basic and diluted EPS for the quarter were ₹26.84, down from ₹37.32 in Q1FY25.
Total expenses increased to ₹8,187 million, mainly due to higher employee and other costs.
Outlook and guidance
Most earnings expected in the first half of the year, with a decline anticipated post-September.
Guidance maintained for a 20% drop in revenue and profit for FY26.
R&D expenses to remain high in Q2, then decline in subsequent quarters.
Pipeline includes 28 Para IVs in the US, with over 20 first-to-file opportunities.
No specific revenue guidance for FY27 due to business uncertainties.
What is the expected timeline for NRC-2694 enrollment?
Why didn't NATCO invest in Eyestem's Series B?
What is NATCO's strategy for Adcock shares?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next NATCO Pharma earnings date
Q2 202610 Nov, 2025
Next NATCO Pharma earnings date
Q2 202610 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
NATCO Pharma Limited is a pharmaceutical company specializing in the development, manufacturing, and marketing of generic and specialty pharmaceuticals. The company produces a range of pharmaceutical products, including oncology, cardiology, and central nervous system medications, focusing on affordable therapies for complex health conditions. NATCO Pharma serves both domestic and international markets, providing formulations and active pharmaceutical ingredients (APIs) to healthcare providers and distributors. The company is headquartered in Hyderabad, India, and its shares are listed on the NSE and BSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage